#+TITLE: Neonatal Hyperammonemia
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

#+LaTeX_CLASS: beamer
#+LaTeX_CLASS_OPTIONS: [presentation, smaller]
#+BEAMER_THEME: Boadilla [height=20pt]
#+BEAMER_COLOR_THEME: [RGB={170,160,80}]{structure}
#+BEAMER_FRAME_LEVEL: 2
#+COLUMNS: %40ITEM %10BEAMER_env(Env) %9BEAMER_envargs(Env Args) %4BEAMER_col(Col) %10BEAMER_extra(Extra)
#+OPTIONS: H:2 toc:nil
#+PROPERTY: header-args:R :session *R*
#+PROPERTY: header-args :cache no
#+PROPERTY: header-args :tangle yes
#+STARTUP: beamer
#+STARTUP: overview
#+STARTUP: hidestars
#+STARTUP: indent
# #+BEAMER_HEADER: \subtitle{What is an Automated and Reproducible Report?}
#+BEAMER_HEADER: \institute[NSO]{Newborn Screening Ontario | The University of Ottawa}
#+BEAMER_HEADER: \titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
#+latex_header: \hypersetup{colorlinks,linkcolor=white,urlcolor=blue}
#+LaTeX_header: \usepackage{textpos}
#+LaTeX_header: \usepackage[version=4]{mhchem}
#+LaTeX_header: \usepackage{chemfig}
#+LaTex_HEADER: \usepackage[usenames,dvipsnames]{xcolor}
#+LaTeX_HEADER: \usepackage[T1]{fontenc}
#+LaTeX_HEADER: \usepackage{lmodern}
#+LaTeX_HEADER: \usepackage{verbatim}

#+BEGIN_LaTeX
\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}~%
    \includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}%
}

\vspace{220pt}}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}

% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}

#+END_LaTeX

# http://www.medscape.org/viewarticle/876755_transcript

* Background
** Production
- Ammonia is produced via the metabolism of nitrogen containing compounds:
  - amino acids
  - purines and pyrimidines
- Intestinal bacteria produce ammonia by splitting urea in the gut.
- Ammonia in the body of a healthy individual is typically present as ammonium ions.
\centering
  \ce{NH4+ <=>[pKa = 9.3] NH3 + H+}
- Ammonium ions cannot cross membranes

** Transport from Muscle: Glucose/Alanine Cycle 
\centering
   [[./figures/glucose_alanine_cycle.png]]

** Transport from Muscle: Glutamine
\centering
   [[./figures/nitrogen_glutamine.png]]

** COMMENT Exchange: Glutamate
\centering
   [[./figures/nitrogen_glutamate.png]]

# #+BEGIN_LaTeX
# \centering
# \chemname{\chemfig{H_2{\color{red}N}-[1](=[2]O)-[7]{\color{red}N}H_2}}{Urea}
# #+END_LaTeX

** Urea Cycle: Next Session UCD
\centering
   [[./figures/urea_cycle.png]]

** Liver Lobule
\centering
[[./figures/liver_lobule.png]]

- periportal hepatocytes :: \uparrow capacity, \downarrow affinity
- perivenous hepatocytes :: \downarrow capacity, \uparrow affinity


# This simplified graph focuses on periportal and perivenous hepatocytes
# as the two ammonia detoxifying com- partments in liver. Ammonia is
# metabolized with high capacity but low affinity in the urea cycle
# which is solely expressed in periportal hepatocytes. As back-up,
# ammonia is detoxified by the action of glutamine syn- thetase that is
# solely expressed in perivenous hepatocytes and has a low capacity but
# high affinity towards ammonia. Urea and glutamine re-enter the cir-
# culation to be excreted in urine or further metabolized in the kidney,
# respectively. Urea


* Laboratory
** Measurement at CHEO

- The VITROS AMON Slide has a multilayered analytical element coated
  on a polyester support.
- A drop of patient sample is deposited on the slide.
- An  alkaline buffer converts ammonium ions to gaseous ammonia. 
- A semipermeable membrane allows only ammonia to pass through
- After incubation the reflection density of the dye is measured.

*** 
\centering
\ce{NH3 + bromophenol blue -> blue dye (600 nm)}

***                                                       :B_ignoreheading:
:PROPERTIES:
:BEAMER_env: ignoreheading
:END:
- bromophenol blue changes from yellow at pH 3.0 to blue at pH 4.6

** Measurement at TOH
- The Dimension Vista Ammonia (AMM) method uses glutamate dehydrogenase (GLDH) and a NADPH analog.

*** 
\centering
\ce{\alpha-ketoglutarate + NH4+ + NADPH ->[GLDH] L-glutamate + NADP+ + H2O}

***                                                       :B_ignoreheading:
:PROPERTIES:
:BEAMER_env: ignoreheading
:END:
- The decrease in absorbance due to the oxidation of the reduced
  cofactor is monitored at 340/700 nm and is proportional to the
  ammonia concentration.

** Point of Care Ammonia Meters
*** PocketChem BA
- blood ammonia analysis used in veterinary medicine.
- [[http://www.woodleyequipment.com/laboratory-diagnostics/clinical-chemistry/pocketchem-ba-blood-ammonia-analyser-474-140-.php][link]]
- [[http://onlinelibrary.wiley.com/doi/10.1111/j.1939-165X.2008.00024.x/abstract;jsessionid=365F3D4A44D8D11C6511CA0B223D065B.f03t03][validation]]

*** Brannelly, N. (2017) PhD, University of the West of England.
-The development of a point of care device for measuring blood ammonia.
- polyaniline nanoparticle ink 

** Ammonia Interpretation 
- In a healthy person, ammonia is relatively tightly controlled;
*** CHEO
| Age              | RI (umol/L) | Critical |
|------------------+-------------+----------|
| 0-<1 month       |       10-55 |      >55 |
| 1-<3 months      |         <30 |      >55 |
| 3 months-<18 yrs |         <30 |     >100 |
| >18 years        |         <30 |     >200 |

*** TOH 
| Age | RI (umol/L) | Critical |
|-----+-------------+----------|
| All |         <35 | None     |


* Clinical
** Neonatal Symptoms
***                                                                 :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:
- poor feeding
- vomiting
- seizures
- respiratory distress
- poor peripheral blood circulation
***                                                                 :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:
- hypotonia
- vomiting
- "abnormal neurologic changes"
  - stupor
- inhibition of insulin secretion
*** Outcome
- outcome \propto $\frac{1}{duration + [\ce{NH4+}]}$
  - irreparable brain damage
** Causes of Hyperammonemia
*** Increased ammonia production
- High protein diets
- Massive hemolysis
- Parenteral nutrition with high nitrogen content
- Protein catabolism (kwashiorkor)
- Infection
- *Pre-analytical*

*** Decreased ammonia elimination
- liver disease
- IEM
  - urea cycle defects
  - fatty acid oxidation defects
  - organic acidemias

** Pre-analytical Considerations in Ammonia Testing
- Capillary ammonia is significantly higher than arterial and venous
  - Capillary samples - sweat contamination
- Delayed analysis
  - erythrocytes and platlets \to ammonia
  - GGT activity
  - Serum is unsuitable
- Hemolysis -  \uparrow [ammonia] RBC
- Detergent contamination

** Specimen Collection and Handling
- Free flowing venous or arterial sample
- Pre-chilled lithium heparin (green top)
- Transport on ice
- Separated w/in 15 min of collection
- Analysed immediately
- Once separated stable: 4 hr @ 4\textdegree C , 24hr @-20\textdegree C

** Biochemical Testing in Neonate with Hyperammonemia
- First line
  - Blood gas analysis
    - UCD \to Respiratory alkalosis
    - UCD rarely acidotic
    - Acidosis suggests OAD or mitochondrial disorder.
  - Urea
  - Glucose
    - hypoglycemia - FAOD, HI, liver failure
  - Liver Function tests
  - Lactate
    - mitochondrial disorders,organic acidemias and FAODs

- Specialist Investigations
  - Urine and Plasma amino acids
    - citruline
    - argininosuccinic acid
  - Urine Organic Acids
    - orotic acid

** Differential Diagnosis in the Neonate

***                                                                   :BMCOL:
    :PROPERTIES:
    :BEAMER_col: 0.5
    :END:

- Sepsis
- Liver dysfunction
- Portocaval shunt
- Perinatal asphyxia
- Sampling artifact


***                                                                   :BMCOL:
    :PROPERTIES:
    :BEAMER_col: 0.5
    :END:

- IEMs
  - Urea cycle disorders
  - Organic acidemias
  - Fatty acid oxidation disorders
  - Mitochondrial disorders
  - Amino acid transporter deficiency

*** 
Inborn errors of metabolism are a very important part of the differential diagnosis in a neonate who has hyperammonemia -- 100 umol/L or higher

** Differential Diagnosis in the Neonate
\centering
[[./figures/THANvIEM.png]]

** Ammonia Interpretation

| Ammonia (umol/L) | Conditions         |
|------------------+--------------------|
| > 1500           | THAN               |
| > 600            | UCD, PA, Valproate |
| 200 - 600        | OA, FAOD,          |
| < 200            | Acquired           |


** References
- http://www.metbio.net/metbioGuidelines.asp
- Hudak, M. L., Jones, M. D., & Brusilow, S. W. (1985).
  Differentiation of transient hyperammonemia of the newborn and urea
  cycle enzyme defects by clinical presentation. The Journal of
  Pediatrics, 107(5), 712–719.
- Haberle, J. (2011). Clinical practice: The management of
  hyperammonemia. European Journal of Pediatrics, 170(1), 21–34.
- Auron, A., & Brophy, P. D. (2012). Hyperammonemia in review:
  Pathophysiology, diagnosis, and treatment. Pediatric Nephrology,
  27(2), 207–222.
